DBV Technologies SA (DBVT)
21.06
+0.56
(+2.73%)
USD |
NASDAQ |
Apr 02, 16:00
21.10
+0.04
(+0.19%)
After-Hours: 20:00
DBV Technologies Research and Development Expense (TTM) : 107.07M for Dec. 31, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| EDAP TMS SA | 9.632M |
| Cellectis SA | 75.00M |
| Akari Therapeutics Plc | 2.820M |
| Biodexa Pharmaceuticals Plc | 5.234M |
| NuCana Plc | 16.89M |